StockClub

AUPH

AUPHAurinia Pharmaceuticals Inc.$ --
Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Inc.

AUPH

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
78M USD
YoY +24.4%
Operating Income
41M USD
YoY +89.6%
Net Income
34M USD
YoY +47.2%
EPS
0.26$
YoY +62.5%

Revenue

$77.7M
FY2024 Q2$107.5M
$107.5M
Q2
FY2024 Q3$175.3M
$175.3M
Q3
FY2024 Q4$235.1M
$235.1M
Q4
FY2025 Q1$62.5M
$62.5M
Q1
FY2025 Q2$132.5M
$132.5M
Q2
FY2025 Q3$205.9M
$205.9M
Q3
FY2025 Q4$283.1M
$283.1M
Q4
FY2026 Q1$77.7M
$77.7M
Q1
Actual
+$15.2M (+24.4%)

Net Income

$34.4M
FY2024 Q2$-10M
$-10M
Q2
FY2024 Q3$4.3M
$4.3M
Q3
FY2024 Q4$5.8M
$5.8M
Q4
FY2025 Q1$23.3M
$23.3M
Q1
FY2025 Q2$44.9M
$44.9M
Q2
FY2025 Q3$76.4M
$76.4M
Q3
FY2025 Q4$287.2M
$287.2M
Q4
FY2026 Q1$34.4M
$34.4M
Q1
Actual
+$11M (+47.2%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020BEAT
Actual:$50.1M
Est:$11.2M
FY2020BEAT
$50.1M
FY2021BEAT
Actual:$45.6M
Est:$43.9M
FY2021BEAT
$45.6M
FY2022BEAT
Actual:$134M
Est:$133.5M
FY2022BEAT
$134M
FY2023MISS
Actual:$175.5M
Est:$207.1M
FY2023MISS
$175.5M
FY2024MISS
Actual:$235.1M
Est:$235.7M
FY2024MISS
$235.1M
FY2025BEAT
Actual:$283.1M
Est:$280.6M
FY2025BEAT
$283.1M

Analyst Estimates